Kiromic BioPharma (NASDAQ:KRBP) & Cellectis (NASDAQ:CLLS) Financial Survey theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 78,600 shares, a growth of 165.5% from the June 30th total of 29,600 shares. Approximately 6.9% of the shares of the stock are short sold. Based […]
Kiromic BioPharma Welcomes Two New Directors to its Board | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Clinical and Regulatory Affairs Expert Pamela Misajon Brings Drug-Development Expertise
Finance and Technology Executive Michael Catlin to Chair the Audit Committee
.
Kiromic BioPharma (KRBP) Welcomes Two New Directors to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.